TCL Archive Gleevec Improves Survival Of CML In Accelerated Phase By Cancer History Project December 27, 2002
TCL Archive Phase II Study Tests Chemo Plus Mylotarg For AML By Cancer History Project December 27, 2002
TCL Archive “Proof Of Concept” Shown In Early Trial Of PKC-412 By Cancer History Project December 27, 2002
TCL Archive Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis By Cancer History Project December 27, 2002
TCL Archive Clinical Trials Approved By NCI During November Are Listed By Cancer History Project December 27, 2002
TCL Archive As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray By Cancer History Project December 13, 2002
TCL Archive Texas Oncology Designated Aranesp As Preferred Treatment By Cancer History Project December 13, 2002
TCL Archive Foundation Gives $1 Million To UPCI For Genetics Chair By Cancer History Project December 13, 2002
Article Latino oncology leaders discuss representation in clinical trials, translational research, and health care By Cancer History Project